Ionis Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 8 | -$1.03 | -$1.03 | -$1.03 |
| Q2 2024 | 5 | -$0.93 | -$0.93 | -$0.93 |
| Q3 2024 | 13 | -$1.26 | -$0.90 | -$1.12 |
| Q4 2024 | 7 | -$1.10 | -$1.10 | -$1.10 |
| Q1 2025 | 8 | -$1.17 | -$1.17 | -$1.17 |
| Q2 2025 | 9 | -$1.11 | -$1.11 | -$1.11 |
| Q3 2025 | 10 | -$1.02 | -$1.02 | -$1.02 |
| Q4 2025 | 11 | -$0.93 | -$0.93 | -$0.93 |
Ionis Pharmaceuticals, Inc. Earnings Date And Information
Ionis Pharmaceuticals, Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.45 earnings per share for the quarter, topping analysts' consensus estimates of $-0.95 by $0.5. The company had revenue of 225.25 M for the quarter and had revenue of 787.65 M for the year. Ionis Pharmaceuticals, Inc. has generated $-3 earnings per share over the last year ($-2.56 diluted earnings per share) and currently has a price-to-earnings ratio of -15.46. Ionis Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Ionis Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/01/2024 | Q2 2024 | -$0.95 | -$0.45 | 0.5 | $156.09 M | $225.25 M |
| 03/29/2024 | Q1 2024 | -$0.98 | $119.50 M | |||
| 02/21/2024 | Q4 2023 | -$0.78 | -$0.06 | 0.72 | $324.51 M | |
| 11/02/2023 | Q3 2023 | -$1.01 | -$1.03 | -0.02 | $136.86 M | $144.00 M |
| 08/09/2023 | Q2 2023 | -$0.94 | -$0.59 | 0.35 | $140.44 M | $188.00 M |
| 05/03/2023 | Q1 2023 | -$1.00 | -$0.87 | 0.13 | $131.00 M | |
| 02/22/2023 | Q4 2022 | -$1.06 | -$0.37 | 0.69 | $152.00 M | |
| 11/09/2022 | Q3 2022 | -$0.74 | -$0.33 | 0.41 | $143.95 M | $159.77 M |
| 08/09/2022 | Q2 2022 | -$0.61 | -$0.74 | -0.13 | $140.54 M | $133.79 M |
| 05/04/2022 | Q1 2022 | -$0.68 | -$0.46 | 0.22 | $141.92 M | |
| 02/24/2022 | Q4 2021 | $1.59 | $440.00 M | |||
| 11/03/2021 | Q3 2021 | -$0.53 | -$0.58 | -0.05 | $160.15 M | $133.09 M |
| 08/04/2021 | Q2 2021 | -$0.56 | -$0.57 | -0.01 | $129.16 M | $125.75 M |
| 05/05/2021 | Q1 2021 | -$0.48 | -$0.64 | -0.16 | $111.61 M | |
| 02/24/2021 | Q4 2020 | $0.24 | -$2.43 | -2.67 | $290.00 M | |
| 11/04/2020 | Q3 2020 | -$0.09 | -$0.22 | -0.13 | $182.14 M | $160.08 M |
| 08/05/2020 | Q2 2020 | -$0.28 | -$0.23 | 0.05 | $148.87 M | $145.54 M |
| 05/06/2020 | Q1 2020 | -$0.11 | -$0.35 | -0.24 | $133.37 M | |
| 03/02/2020 | Q4 2019 | $1.31 | $494.00 M | |||
| 11/06/2019 | Q3 2019 | -$0.32 | $0.19 | 0.51 | $153.80 M | $167.89 M |
Ionis Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Ionis Pharmaceuticals, Inc.'s earnings date?
Ionis Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Ionis Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Ionis Pharmaceuticals, Inc. (:IONS) reported $-0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.95 by $0.5.
-
How can I listen to Ionis Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Ionis Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Ionis Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Ionis Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Ionis Pharmaceuticals, Inc. generate each year?
Ionis Pharmaceuticals, Inc. (:IONS) has a recorded annual revenue of $787.65 M.
-
How much profit does Ionis Pharmaceuticals, Inc. generate each year?
Ionis Pharmaceuticals, Inc. (:IONS) has a recorded net income of $787.65 M. Ionis Pharmaceuticals, Inc. has generated $-2.56 earnings per share over the last four quarters.
-
What is Ionis Pharmaceuticals, Inc.'s price-to-earnings ratio?
Ionis Pharmaceuticals, Inc. (:IONS) has a price-to-earnings ratio of -15.46 and price/earnings-to-growth ratio is -2.94.
